About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Peptide Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH/MASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×

news

Company News Events Insights Webinars Virtual Tours

New Strategies Required to Meet Changing Needs in the Analytical Services Market

BioDuro introduces standalone analytical services to meet the growing demand for high-quality, rapid, cost-effective testing in the competitive pharmaceutical market
December 31, 2016

BioDuro Increases Spray Dried Drug Product Manufacturing Capacity

BioDuro expands spray drying capacity with the SPX Anhydro MicraSpray 150, enhancing solubility for drug candidates from preclinical to Phase 3 trials
November 08, 2016

Sundia Selected as a Red Herring Top 100 Asia Company

Sundia recognized as Red Herring Top 100 Asia winner for 2016, highlighting its pivotal role in advancing drug discovery and development for global partners
September 14, 2016

Sundia congratulates Betta Pharmaceuticals for X-396 IND approval in China

Sundia congratulates Betta Pharmaceuticals on obtaining CFDA IND approval for X-396, advancing treatment for ALK-positive NSCLC patients. Moving you Forward
August 31, 2016

BioDuro Completes Infrastructure Expansion in Shanghai

BioDuro expands infrastructure at its Shanghai facility, enhancing capabilities in drug discovery and development with new labs and increased capacity.
August 25, 2016
Total 85 12...91011121314151617
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all